Data as of Sep 14, 2026 · Based on 3,293,187 AI responses across 10,525 prompts · See how Parse measures this
Zepboundzepbound.lilly.comZepbound (tirzepatide) is a prescription injectable medicine for adults with obesity or overweight who have weight-related medical problems, intended to help them lose weight and keep it off when used with a reduced-calorie diet and increased physical activity. It may also improve moderate-to-severe obstructive sleep apnea in adults with obesity and is marketed as the #1 most prescribed weight-management medicine, now available in KwikPen for self-pay pricing. Safety notes include potential thyroid tumor risk, a starting dose of 2.5 mg that is not an approved maintenance dose, and guidance to avoid mixing with other tirzepatide or GLP-1 receptor agonists, with savings options available for coverage.
Eli Lilly and CompanyZepboundThe market map · 5 of 69 labelled
Online Health Products & Pharma Services →26%positive
Where Zepbound ranks in AI
fda-approvedmost effectivelegitimateprescriptionreputablestrongestbrand-nameunapproved
Wegovyco-mentionedCompare →Excerpts where Zepbound appeared in the AI's answer
Zepbound (tirzepatide) — often among the strongest appetite/weight-loss medications available.
Zepbound (tirzepatide) – Usually produces the greatest average weight loss among currently approved medications.
